IL25 and allergic asthma: Inhibition of IL-25 signaling, e.g., by an IL-25 neutralizing antibody, diminishes allergic airway inflammation, airway hyperresponsiveness, and airway remodeling in mouse models of experimental allergic asthma [245,246].